Meredith W. Mendes
Meredith W. Mendes's purchase track record
Meredith W. Mendes has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/8/2021 | NX | $15K | +13.6% | -4.2% | +2.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Kronos Worldwide Shares Up 72% Year-to-Date. Kronos Worldwide stock has risen 72% since the start of the year, outperforming many peers in the basic materials sector. This significant gain places the stock near the upper end of its 52-week range, despite a current RSI of 35.4 suggesting recent cooling in momentum. The company also offers a high dividend yield of 8.93%.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Quanex Q2 Earnings Compared to Home Construction Peers. Quanex Building Products released its second-quarter earnings, which are being compared against other home construction materials companies. This update provides context for how the company is performing relative to its sector. The stock is currently trading near a key support level, reflecting a neutral technical stance while investors digest the new financial results.
Transaction History
| NL | ▲ Buy | Grant | 6,000 | $40K | 5/14/2026 | View on chart |
| KRO | ▲ Buy | Grant | 5,550 | $40K | 5/13/2026 | View on chart |
| NL | ▲ Buy | Grant | 2,500 | $20K | 5/15/2025 | View on chart |
| KRO | ▲ Buy | Grant | 2,800 | $20K | 5/14/2025 | View on chart |
| NL | ▲ Buy | Grant | 2,850 | — | 5/16/2024 | View on chart |
| KRO | ▲ Buy | Grant | 1,550 | — | 5/15/2024 | View on chart |
| NL | ▲ Buy | Grant | 3,550 | — | 5/18/2023 | View on chart |
| KRO | ▲ Buy | Grant | 2,450 | — | 5/17/2023 | View on chart |
| NL | ▲ Buy | Grant | 2,500 | — | 5/19/2022 | View on chart |
| KRO | ▲ Buy | Grant | 1,200 | — | 5/18/2022 | View on chart |
| NX | ▲ Buy | Open Market | 700 | $15K | 10/8/2021 | View on chart |
| NL | ▲ Buy | Grant | 2,750 | — | 5/20/2021 | View on chart |
| NL | ▲ Buy | Grant | 6,650 | — | 5/21/2020 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
NL Upgraded to Outperform on CompX Strength, Kronos Recovery
The rating upgrade reflects a more positive outlook after CompX's strong performance and Kronos's recovery. NL is near its 52‑week low but sits above the $5.65 support level, and the RSI of 59.5 indicates a moderate trend.
NL Upgraded to Outperform on CompX Strength, Kronos Recovery. The rating upgrade reflects a more positive outlook after CompX's strong performance and Kronos's recovery. NL is near its 52‑week low but sits above the $5.65 support level, and the RSI of 59.5 indicates a moderate trend.